Two people start pump therapy the same month with similar insurance. One picks up Omnipod at CVS for a pharmacy copay. The other waits weeks for a prior authorization, then owes 20% coinsurance on a claim that runs thousands of dollars at list. Nothing medical separates them; the pumps entered through different doors. Omnipod bills through the pharmacy benefit like a prescription. Tubed pumps (Tandem, Medtronic, Beta Bionics) bill as durable medical equipment. Almost every dollar question about pumps traces back to that split, so start every pump decision by asking which door your plan uses.
Is Omnipod covered by insurance?
For most insured people, yes, and through the pharmacy. Insulet reports that a majority of commercially insured Omnipod 5 users pay under $30 a month, with more than 40% paying $0, and pods fill at retail and mail-order pharmacies (Walmart, Walgreens, CVS, Amazon) like any prescription. Many plans still gate it behind a prior authorization that renews annually, so calendar the renewal before it lapses into a surprise counter price. Three wrinkles worth knowing: some plans route pods through the DME benefit instead, and Insulet's copay assistance does not apply there, so if you're quoted a DME price, ask whether your plan covers pods on the pharmacy side too. If Omnipod is off-formulary entirely, a formulary exception request (your prescriber attests why pods specifically) is the standard fix. And if you're uninsured or underinsured, Insulet runs a financial assistance program with income-based discounts.
Why do tubed pumps cost so much more upfront?
A tubed pump is one large DME claim, which means your deductible and DME coinsurance apply to the whole device at once, then infusion sets and cartridges bill monthly on the same benefit. The trade: a higher, lumpier cost of entry, and a device the plan expects you to keep for 4 to 5 years. Two moves soften it. Order the pump after your deductible is met (a December pump can cost a fraction of a January one), and know the plan's checklist before the prior auth goes in. Commercial criteria usually look like this:
- Diagnosis and regimen: diabetes treated with intensive insulin therapy, typically multiple daily injections, documented in chart notes.
- Glucose data: recent fingerstick logs or CGM downloads showing testing frequency and the control problem the pump solves (highs, lows, variability).
- Education: completion of diabetes self-management training, or a plan to complete pump training.
- Prescriber documentation: a visit note tying the pump to a clinical need. Denials name which of these boxes the reviewer thinks is empty; make the office fill THAT box and resubmit.
How does Medicare cover insulin pumps?
Tubed pumps are Part B durable medical equipment: Medicare pays 80% of the approved amount after the deductible, and a Medigap plan picks up the 20%, which is why supplement math favors pump users. The criteria live in the External Infusion Pumps coverage policy (LCD L33794), and unlike the CGM rules, which loosened in 2023, the pump criteria did not loosen in the January 2026 update. Expect to document:
- An insulin-intensive history: multiple daily injections with frequent self-adjustment before the pump, or you were already on a pump before enrolling in Medicare.
- Glucose monitoring: documented self-testing or CGM use at the frequency the policy expects.
- Insulin deficiency, proven on paper: a fasting C-peptide at or below 110% of the lab's lower limit of normal (a higher threshold applies with renal insufficiency), or a positive beta-cell autoantibody test. Most type 1s pass easily; insulin-treated type 2s are where this criterion decides the outcome, so get the lab drawn correctly (fasting, with glucose) the first time.
- Ongoing visits: your treating practitioner must see you at least every 3 months, or supply shipments stop silently.
Omnipod takes a different road entirely: Medicare covers it under Part D as a pharmacy-benefit item, usually on tier 3 or 4. That skips the C-peptide gate, and pod costs count toward Part D's $2,100 out-of-pocket cap for 2026, with the Medicare Prescription Payment Plan available to spread the cost across the year. The catch is that tier coinsurance on pods can run higher month to month than a Medigap-covered Part B pump, so price both doors before choosing.
How often will insurance replace a pump?
Two clocks run at once. Manufacturer warranties typically last 4 years (Tandem's runs 4 years from shipment). Medicare's reasonable useful lifetime for DME is 5 years from the delivery date, and before that mark Medicare covers repairs up to the cost of replacement, with early replacement only for equipment that is lost, stolen, or damaged beyond repair. Commercial plans generally follow the warranty: a new pump gets approved when the old one is out of warranty, and denied while it is in warranty and functioning. When your out-of-warranty pump fails, the sequence is:
- Call the manufacturer first and get a case number documenting the malfunction; that case number is the evidence the plan will ask for.
- Get the prescriber's order and a current chart note confirming continued pump therapy (Medicare will also want the every-3-months visit history current).
- Run the new prior authorization through the supplier, citing the malfunction case and the warranty end date.
- If it denies anyway, appeal with the paper trail attached: most documented-malfunction denials reverse because the plan's own policy allows out-of-warranty replacement.
What if your pump upgrade gets denied?
Wanting a newer model while your current pump is in warranty and working reads as convenience to a reviewer, and those denials mostly stick. Two honest paths around one. If the new pump's features matter clinically (an automated-delivery algorithm for documented severe hypoglycemia, a sensor integration your current pump lacks), that is a medical-necessity appeal, and the prescriber's letter should name the clinical problem and why the current device cannot solve it. If it's preference, skip insurance: manufacturers sell the switch directly, with Medtronic's Pump Pathway putting eligible users into a MiniMed 780G for $399 and Tandem's upgrade program moving non-Tandem users over for $999, both requiring at least 6 months left on your current warranty. Otherwise, calendar your warranty end date; the month it expires, you're a routine approval instead of an uphill appeal.
How Kite handles this
Kite works the pump file so you don't: it checks which channel each pump runs through on your specific plan (pharmacy tier for pods, DME coinsurance for tubed), assembles the prior-auth checklist with the exact documentation your prescriber must send, calendars the auth renewal, the warranty end, and the 5-year Medicare clock, then drafts the appeal with the malfunction case number attached when a replacement or upgrade denial lands. Text Kite to start.
